ETESEVIMAB

Investigational

Approval Year

Name

Type

Language

LY-3832479

Preferred Name

English

ETESEVIMAB

Official Name

English

ANTI-SARS-COV-2 ANTIBODY JS016

Common Name

English

CB6

Code

English

JS016

Code

English

NP-005

Code

English

LY COV016

Code

English

LY3832479

Code

English

IMMUNOGLOBULIN G1*03-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHV3-66*01 (97%) (IGHD)-IGHJ4*01 (93%)) (8.7.13) (1-119)-

Common Name

English

CB-6

Code

English

Etesevimab [WHO-DD]

Common Name

English

JS-016

Code

English

etesevimab [INN]

Common Name

English

ETESEVIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER

Common Name

English

IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER

Common Name

English

NP005

Code

English

LY-COV016

Code

English

Code System Code Type Description

CAS

2423948-94-9